Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008244
Filing Date
2022-05-09
Accepted
2022-05-09 07:58:14
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cmpx-20220331.htm   iXBRL 10-Q 1289349
2 EX-31.1 cmpx-ex31_1.htm EX-31.1 17863
3 EX-31.2 cmpx-ex31_2.htm EX-31.2 18238
4 EX-32.1 cmpx-ex32_1.htm EX-32.1 10497
5 EX-32.2 cmpx-ex32_2.htm EX-32.2 10520
6 EX-99.1 cmpx-ex99_1.htm EX-99.1 174049
7 GRAPHIC img119605530_0.jpg GRAPHIC 305119
8 GRAPHIC img119605530_1.jpg GRAPHIC 407744
9 GRAPHIC img174977587_0.jpg GRAPHIC 100660
  Complete submission text file 0000950170-22-008244.txt   7296924

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmpx-20220331.xsd EX-101.SCH 46809
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmpx-20220331_def.xml EX-101.DEF 178119
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmpx-20220331_lab.xml EX-101.LAB 413583
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmpx-20220331_pre.xml EX-101.PRE 301522
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmpx-20220331_cal.xml EX-101.CAL 42814
54 EXTRACTED XBRL INSTANCE DOCUMENT cmpx-20220331_htm.xml XML 903364
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 22903282
SIC: 2836 Biological Products, (No Diagnostic Substances)